PRO Consortium Announces Publication of Open Access Article

C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures” was published by Quality of Life Research on July 19, 2022. The article presents the data collected by three PRO Consortium working groups to identify stable samples for test-retest reliability analyses for their PRO measures qualified through FDA’s COA Qualification Program.

Access here: